Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 53,919 | 99,067 | 71,079 | 62,629 | 50,767 |
| Cost of Goods | 9,317 | 7,985 | 10,359 | 9,048 | 8,831 |
| Gross Profit | 44,602 | 91,082 | 60,720 | 53,581 | 41,936 |
| Operating Expenses | 70,699 | 82,219 | 79,615 | 64,910 | 84,211 |
| Operating Income | -25,780 | 9,848 | -18,536 | -11,281 | -41,444 |
| Interest Expense | 4,448 | 4,443 | 3,820 | 3,499 | 2,587 |
| Other Income | -7,196 | -15,492 | -8,321 | 579 | -304 |
| Pre-tax Income | -37,424 | -10,087 | -30,677 | -14,201 | -44,335 |
| Net Income Continuous | -37,424 | -10,087 | -30,694 | -14,201 | -44,335 |
| Net Income | $-37,424 | $-10,087 | $-30,694 | $-14,201 | $-44,335 |
| EPS Basic Total Ops | -0.97 | -0.26 | -0.80 | -0.37 | -1.17 |
| EPS Basic Continuous Ops | -0.97 | -0.26 | -0.80 | -0.37 | -1.17 |
| EPS Diluted Total Ops | -0.97 | -0.26 | -0.80 | -0.37 | -1.17 |
| EPS Diluted Continuous Ops | -0.97 | -0.26 | -0.80 | -0.37 | -1.17 |
| EBITDA(a) | $-23,680 | $11,983 | $-16,431 | $-9,226 | $-39,561 |